JEFFREY E GERSHENWALD to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications JEFFREY E GERSHENWALD has written about Randomized Controlled Trials as Topic.
Connection Strength
0.106
-
Melanoma. Oncologist. 2001; 6(5):402-6.
Score: 0.026
-
KEYNOTE-716: Phase III study of adjuvant pembrolizumab versus placebo in resected high-risk stage II melanoma. Future Oncol. 2020 Jan; 16(3):4429-4438.
Score: 0.024
-
Lifestyle Modifications and Policy Implications for Primary and Secondary Cancer Prevention: Diet, Exercise, Sun Safety, and Alcohol Reduction. Am Soc Clin Oncol Educ Book. 2018 May 23; 38:88-100.
Score: 0.021
-
Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis. Lancet Oncol. 2018 03; 19(3):310-322.
Score: 0.021
-
Future perspectives in melanoma research. Meeting report from the "Melanoma research: a bridge from Naples to the World. Napoli, December 5th-6th 2011". J Transl Med. 2012 Jul 04; 10:83.
Score: 0.014